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1. Introduction
  Exposure to various environmental factors leads to free 
radical formation. The most common form of free radicals 
is oxygen. When an oxygen molecule (O2) becomes 
electrically charged, it tries to steal electrons from other 
molecules, causing damage to the DNA and other molecules 
and therefore cause mutagenesis. A critical factor in 
mutagenesis is cell division[1]. When the cell divides, an 
unrepaired DNA lesion can give rise to mutation. To protect 
against oxidative damage, animals have many different 
types of antioxidants defenses, these antioxidants decrease 
mutagenesis and carcinogenesis, in two ways: by decreasing 
oxidative DNA damage and by decreasing cell division[2].  
  Naturally occurring substances of plant origin and 
dietary components that have been widely studied for 
their antimutagenic activity were studied, which includes 
carotenoids, flavonoids, tea-polyphenols, vitamins, 
cucuminoids, tannins, coumarins, chlorophyllin, porphyrins 
and alkylresorcinols from cereal grains. It is now well 
recognized that the antioxidants and antimutagenic 
phytochemicals also play an important role in prevention 
of cancer. Hence, there is a need to establish the relations 
between antioxidants and antimutagenic agents[3]. 
  Cyclophosphamide is an alkylating agent widely used in 
cancer chemotherapy. Its cytotoxic effects are the result 
of chemically reactive metabolites that alkylate DNA and 
protein, producing cross-links. The injury of normal tissues 
is the major limitation of using cyclophophomide, which 
gives rise to numerous side effects. It has been reported 
that oxidative stress mediated disruption of redox balance 
after cyclophophomide exposure generates biochemical and 
physiological disruptances[4]. Several studies suggest that 
antioxidant supplementation can influence the response 
to chemotherapy as well as the development of adverse 
side effects that result from treatment with antineoplastic 
agents[5].  
  Buchanania lanzan Spreng. (B. lanzan) belongs to the 
Family Anacerdiaceae, is commonly known as ‘Chaar’ 
in India and ‘Almondette tree’ in English. In ayurvedic 
medicine various part this plant used as astringent, 
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depurative, constipating, brain tonic, cardiotonic and for 
glandular swelling[6]. This plant is used in treatment and 
prevention of cancer by traditional healers and herbalists of 
the Chhattisgarh state of India[7]. Furthermore, antioxidant 
activity of its bark has been described by us and other 
authors[8-10]. The phytoconstitute reported in bark of this 
plant tannins, quercetin, gallic acid and glucoside[6, 11]. High 
content of polyphenoles, in vitro antioxidant activity and 
traditional use of this plant in prevention of cancer, compel 
to investigate the effect of ethanol extract of Buchanania 
lanzan bark against cyclophophomide-induced genotoxicity 
and oxidative stress in mice. 
2. Materials and methods
2.1. Plants  
  The bark of B. lanzan were collected from forest of Pendra, 
district Bilaspur Chhattisgarh, India during the month of 
December 2008. The plant was identified and authenticated 
by Dr. H. B. Singh, Scientist, National Institute Scientific 
Communication and Research (NISCAIR) New Delhi, India. 
The voucher specimen has been stored in herbarium of 
SLT institute of Pharmaceutical Sciences, Bilaspur India 
for future reference (Specimen No. 03/HSBL). The bark 
of B. lanzan was dried in shade and powdered. Dried 
powder was extracted with petroleum ether (60-80 曟) and 
filtered. The residue was extracted with 90% ethyl alcohol 
by using Soxhlet extraction apparatus. Then solvent was 
completely removed under reduced pressure and controlled 
temperature. The crude extract obtained was a dark brown 
solid (yield of the extract was 18.5%). 
2.2. Chemicals  
  Folin-Ciocalteu reagent, cyclophophomide,  bovine serum 
albumin, thiobarbituric acid (TBA), sodium azide,  nitro blue 
tetrazolium (NBT), NADH, 5,5’-dithio-bis(2- nitrobenzoic 
acid) (DTNB), phenazine methosulphate were obtained from 
HIMEDIA, Mumbai, India. All other chemical used were of 
analytical grade. 
2.3. Phytochemcal analysis and total polyphenol content
  The ethanol extract B. lanzan was subjected to preliminary 
phytochemical screening to identify the presence of various 
phytoconstituents present in the extract[12]. 
  Content of total polyphenol was determined according 
to method of folin-ciocalteu reaction[13]. Different 
concentrations of Gallic acid (10-50 毺g/mL) were prepared 
for standard curve. 0.1 mL of these different concentrations of 
Gallic acid was taken in different test-tubes and to it 0.5 mL
undiluted Folin-Ciocalteu reagent was added. After 1 min, 
1.5 mL 20 % (w/v) anhydrous sodium carbonate were added 
and volume was made up to 10 mL with water. After 1 hour 
incubation at 25 曟, the absorbance was measured at 760 nm.
0.1 mL of extracts (1 mg/mL in methanol) was taken and 
followed as above. Absorbance of this sample was taken 
and Gallic acid equivalent was determined by extrapolation 
of the standard curve. The total phenolic content was 
expressed as Gallic Acid Equivalents (GAE) in microgram 
per milligram of extract. 
2.4. Animals
  Male albino mice [10 week old, 20-25 g, body weight 
(bw)] were used from animal house facilities of School of 
Pharmacy, CEC, Bilaspur, India. The animals were fed 
with a standard pellets diet and drinking water ad libitum. 
The study was approved by Animal Institutional Ethics 
Committee (IACE) (CPCSEA Reg.: 1275/ac/09/CPCSEA)
  The animals were divided into 7 groups (Group I-VII) of six 
animals each:
  Group I:  Normal control received distilled water (10 mL/kg, bw) 
for 7 days by gavage.   
  Group II:  Vehicle control received 2% acacia (10 mL/kg, bw) 
for 7 days by gavage.     
  Group III: Positive control, treated with single dose 
cyclophosphamide (i.p. 75 mg/kg, bw) in saline, 1 h after 
the last dose of distilled water (10 mL/kg, bw) for 7 days by 
gavage. 
  Group IV: Treated with single i.p. dose of cyclophosphamide, 
1 h after the last dose of B. lanzan extract (250 mg/kg, BW for 7 
days) in 2% acacia (10 mL/kg, bw) by gavage.
  Group V: Treated with single i.p. dose of cyclophosphamide, 
1 h after the last dose of B. lanzan extract (500 mg/kg, BW for 
7 days) in 2% acacia (10 mL/kg, bw) by gavage. 
Group VI: Treated with single i.p. dose of cyclophosphamide, 
1 h after the last dose of B. lanzan  extract (1 000 mg/kg, BW 
for 7 days) in 2% acacia (10 mL/kg, bw) by gavage.
  Group VII: Extract control treated with B. lanzan extract 
(1000 mg/kg, bw for 7 days) in 2% acacia (10 mL/kg, bw) by 
gavage.
2.5. Determination of micronuclei in bone marrow
  After treated with cyclophophomide for 30 h, mice were 
sacrificed by cervical dislocation. Bone marrow cells of 
both femurs were flushed through a 21-gauge needle using 
a disposable syringe into a centrifuge tube containing 1 
mL of 5 % bovine albumin solution. This suspension was 
centrifuged at 1 000 rpm for 5 min. The pellet of cells was 
resuspended in a drop of fresh bovine albumin solution and 
smears were prepared on clean glass slides and air-dried. 
Four slides were prepared for each mouse. The dried, evenly 
spread bone marrow smears were fixed with methanol for 
5 min and stained with May-Grunwald and Giemsa as 
Ritesh Jain et al./Asian Pacific Journal of Tropical Medicine (2012)187-191 189
described by Schmid[14]. A total of 1 000 polychromatic 
erythrocytes (PCE) were screened per animal by the same 
observer for determining the frequency of polychromatic 
erythrocytes (PCE) containing micronuclei (MNPCE) and 
the ratio of PCE: NCE was also determined by counting the 
number of PCEs among 300 erythrocytes.
2.6. Lipid peroxidation and antioxidant enzymes
  The effects of treatments on lipid peroxidation and 
antioxidant enzymes were determined by corresponding 
assays in every group.  Livers were removed from mice and 
perfused immediately with ice-cold saline (0.9% sodium 
chloride) and homogenized in chilled phosphate buffer (0.1 M,
pH 7.4) using tissue homogenizer. The homogenate was 
centrifuged at 4 000 rpm for 5 min at 4 曟. Products of 
lipid peroxidation (LPO) were estimated by measuring the 
concentration of malondialdehyde (MDA) expressed as 
thiobarbituric acid reactive substances (TBARS) according 
to the methods of Ohkawa et al.[15] and expressed as nMole 
MDA/mg of protein.  Total superoxide dismutase activity 
(SOD) was determined by the phenazine methosulphate 
method using nitro blue tetrazolium (NBT) and NADH 
to generate superoxide radicals, and a unit of activity 
was defined by Kakkar et al.[16] and expressed as (Unit/
mg of protein).  Catalase activity (CAT) was measured 
spectrophotometrically by measuring the decrease of 
absorbance at 240 nm due to H2O2 decomposition according 
to the methods of Aebi[17] and expressed as (Unit/mg 
of protein). Reduced glutathione (GSH) was estimated 
spectrophotometrically by determination of dithiobis-
2-nitrobenzoic acid (DTNB) reduced by SH-groups, as 
described by Moron et al.[18] and expressed as nmol/mg of 
protein. Protein content of homogenates was determined 
by reaction with coomassie Blue dye, using bovine serum 
albumin as the standard, in a spectrophotometer.
2.7. Statistical analysis
  Values are expressed as mean 依 SEM from 6 animals. 
Statistical difference in mean were analyzed using one way 
ANOVA followed by Tukey’s multiple comparison tests, P < 
0.05 will be considered statically significant. 
3. Results
3.1. Phytochemical analysis and total polyphenol content 
  Preliminary phytochemical study of the ethyl alcohol 
extract of Buchanania lanzan indicated the presence of 
flavonoid, sterol, terpenoids, glycosides and tannins. The total 
polyphenol content was found 30.12 依 0.78 毺g GAE /mg of 
extract.
3.2. Micronuclei in bone marrow
  The results obtained for mice treated with different 
concentrat ions of  B.lanzan  in combination with 
cylcophoshphamide as well as B. lanzan alone are shown 
in Table 1. No significant difference in the frequency of 
MNPCE was observed between mice treated with 1 000 mg/kg
of Buchanania lanzan (Group-VII) and the normal 
control (Group-II).  A high increase in the frequency of 
MNPCE was detected in mice treated with 75 mg/kg of 
cyclophophomide (group-III) compared to the normal 
control (Group-II) (P<0.001). Simultaneous treatments 
with different concentrations of Buchanania lanzan and 
cylcophoshphamide (Group IV, V & VI) led to reduction in 
the frequency of MNPCE compared to cylcophoshphamide 
alone (group-III), which was significant for the treatments 
using 250, 500 and 1 000 mg/kg of B. lanzan with the 
addition of cylcophoshphamide (**P < 0.01 and ***P < 
0.001), corresponding to decreases of 37.2%, 56.14 and 
69.99% in the frequency of MNPCE, respectively. These 
results indicate a dose-response correlation, B. lanzan was 
found to be effective and a gradual increase in concentration 
is proportional increase in the reduction of mutagenicity. 
Evaluation of erythropoietic cytotoxicity is a key 
component of safety assessment in new drug development. 
The occurrence of fewer immature erythrocytes (PCE) 
relative mature or normochromatic erythrocytes (NCE) 
is considered to be an indicator of mutagen-induced 
cytotoxicity. Therefore, the ratio of PCE to NCE is one index 
of cytotoxicity that is routinely included in micronucleus 
tests to assess the mutagenicity of chemicals to mammals. 
No significant differences in the PCE/NCE ratio were 
observed when comparing mice treated with 1000 mg/kg
of B. lanzan (Group VII) and the normal control (Group II). 
This result indicates a lack of toxicity to bone marrow.
3.3. Effect on lipid peroxidation and antioxidant enzymes
  Table 2 represents the extent of lipid peroxidation as 
evidenced by the formation of MDA as well as the levels 
of GSH and activities of the antiperoxidative enzymes 
SOD and CAT in the livers of control and experimental 
animals. The lipid peroxidation levels in mice treated with 
cyclophophomide alone (group III) were significantly higher 
when compared to controls (group I & II), with concomitant 
decrease in the GSH and activities of SOD and CAT. Oral 
pretreatment with Buchanania lanzan at all doses tested 
(group IV, V & VI), significantly prevented these adverse 
changes and maintained the animals at near normal status 
in a dose-dependent manner.
Ritesh Jain et al./Asian Pacific Journal of Tropical Medicine (2012)187-191190
4. Discussion
  Based on the results of the micronucleus assay, 
ch romosomal  damage  was  the  ma jo r  cause  f o r 
the appearance of micronuclei due to exposure to 
cyclophophomide and as an indicator of genotoxic insult 
to nuclei[19]. The fact that administration of 75 mg/kg bw 
i.p. (group III) resulted in a significantly greater frequency 
of MNPCE in bone marrow cells than did distilled water 
or Vehicle groups (I and II) (Table 1) demonstrates the 
genotoxicity of cyclophophomide. Administration of B. lanzan
for 7 days inhibited formation of micronuclei in mouse 
bone marrow cells by cyclophophomide. B. lanzan 
significantly reduced the frequency of MNPCE and 
exhibited protection and anticlastogenic effects against the 
effects of cyclophophomide. Several studies indicate that 
cyclophophomide has a prooxidant character, and generation 
of oxidative stress after cyclophophomide administration 
leads to decrease in the activities of antioxidant enzymes 
and increase in lipid peroxidation (LPO) in liver, lung and 
serum of mice and rats[20 -21]. The greater lipid peroxidation 
(LPO), which is considered to be an indicator of increased 
oxidative damage, suggests that this was a primary effect 
caused by cyclophophomide in mouse liver. Some anticancer 
drugs including cyclophophomide are known to exert their 
cytotoxic effects by a free radical mediated mechanism[22]. 
We noted significant increases of MDA in liver after 
cyclophophomide treatment. Pretreatment and concomitant 
treatment with Buchanania lanzan resulted in significant 
decrease in MDA levels, and this may be due to the free 
radical scavenging potential of the extract. cyclophophomide 
metabolism produces highly reactive electrophiles and the 
decreased value of GSH in cyclophophomide-treated group 
most probably due to the electrophilic burden on the cells 
and also due to the formation of acrolein, which deplete GSH 
content[23-30]. Treatment with Buchanania lanzan reduced 
the electrophilic burden and thereby increased GSH levels in 
liver. Administration of B. lanzan significantly elevated the 
SOD and CAT activities, suggesting that it had the ability to 
restore the activities of these two enzymes. Oxidative stress 
arising from overproduction of ROS and the breakdown of 
antioxidant defenses is documented to induce chromosomal 
breakage and formation of bone marrow micronuclei[31]. It 
has been suggested that clastogenic factors are released by 
cells exposed to oxidative stress[32]. Free radical scavengers, 
including naturally occurring compounds such as vitamin 
C, have been found to reduce or neutralize the activity of 
such reactive oxygen species[22]. These results support the 
hypothesis that cyclophophomide-induced genotoxicity and 
cytotoxicity to bone marrow cells may be partially repaired 
by antioxidant activity. The protective activity of the 
Buchanania lanzan may be due to its inhibitory action on 
several enzymes or it’s blocking effect on oxidative damage.
  In summary, the results of this study demonstrate that 
B. lanzan protects against cyclophophomide-induced 
genotoxicity in mice. The chemopreventive actions of 
B. lanzan in this effect may be partially attributed to its 
elevation of the levels of enzymatic antioxidants (SOD and 
CAT). The present findings imply that B. lanzan may be a 
potential antigenotoxic, antioxidant and chemopreventive 
agent and could be used as an adjuvant in chemotherapeutic 
applications.
Table 1
Frequency of MNPCE and PCE/NCE ratio in mice treated with B. lanzan and/or cyclophashamide after 30 h.
Group Treatment
MNPCE PCE/NCE
Individual data No. % Mean依SEM Mean依SEM
I Distilled water 04-02-03-04-04-03   19 0.31   3.33依0.33 0.84依0.01
II Vehicle (2% acacia) 02-03-04-03-04-03   20 0.33   3.16依0.30 0.82依0.02
III Positive control (CP 75 mg/kg bw i.p.) 18-20-22-24-24-22 130 2.16 21.66依0.95a***   0.57依0.02a*
IV BL extract 250mg/kg + CP 16-13-14-12-12-14   81 1.35 13.50依0.61b** 0.69依0.03
V BL extract 500mg/kg + CP 10-09-11-10-08-09   66 1.10  9.5 0依0.42b*** 0.55依0.05b
VI BL extract 1 000mg/kg + CP 09-06-08-05-04-07   39 0.65   6.50依0.34b*** 0.62依0.13b
VII BL extract 1 000mg/kg 04-03-02-03-02-03   17 0.28   2.83依0.30a 0.91依0.12a
BL: B. lanzan. CP: cyclophashamide; Comparison:  (a) group II vs. III & VII, (b) group III vs. IV, V & VI;  Statistical significance
*P< 0.05), ** P<0.01, *** P<0.001; PCE, polychromatic erythrocytes; NCE, normochromatic erythrocytes; MNPCE, micronucleated 
polychromatic erythrocytes.
Table 2
Levels of lipid peroxidation and antioxidants in livers of mice following treatment with different doses of B. lanzan against CP.
Group Treatment
LPO 







I Distilled water 1.77依0.17 54.16依4.73    12.37依1.25 7.21依0.44
II Vehicle (2% acacia) 1.67依0.20 53.56依1.64    12.82依1.52 7.15依0.38
III Positive control(CP 75 mg/kg wt i.p.)      5.12依0.29a***      25.33依1.63a***      4.69依0.40a***    3.68依0.41a**
IV BL extract 250mg/kg + CP  4.06依0.40b   28.36依3.42b      7.83依0.93b   5.65依0.57b*
V BL extract 500mg/kg + CP    3.23依0.42b**    41.66依3.44b*      9.55依1.10b*    6.05依0.25b**
VI BL extract 1000mg/kg + CP     2.71依0.48b***     44.44依3.87b**    10.82依0.71b**    6.91依0.29b**
VII BL extract 1000mg/kg 1.52依0.12a  54.48依2.48a    12.24依0.95a  7.28依0.40a
Comparison:  (a) group II vs. III & VII, (b) group III vs. IV, V & VI; Statistical significance * P<0.05, ** P<0.01, *** P<0.001.
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